Get Your Story Straight: Patent Office Cracks Down on Inconsistent Statements Made Before the FDA
Bill of Health
SEPTEMBER 29, 2022
In the July 29, 2022 notice, the USPTO set forth its views on the “duty of disclosure” and “duty of reasonable inquiry,” emphasizing the importance of consistency between statements made to the USPTO, the FDA, and other governmental agencies. Background Context. Practical Implications.
Let's personalize your content